Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
US-9446006-B2 · Sep 20, 2016 · US
US9556098B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9556098-B2 |
| Application number | US-201615181511-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 14, 2016 |
| Priority date | Jun 24, 2011 |
| Publication date | Jan 31, 2017 |
| Grant date | Jan 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
With respect to reduced coenzyme Q10, there has been no report about the presence of crystal polymorphism, and it has been considered that a conventionally obtained crystal form is only one form. The present invention relates to a reduced coenzyme Q10 crystal having an endothermic peak indicating melting at 54±2° C. during temperature rise at a rate of 5° C./min by differential scanning calorimetry (DSC), and/or to a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles (2θ±0.2°) of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° by powder X-ray (Cu—Kα) diffraction. The crystal form is a novel reduced coenzyme Q10 crystal which has a higher melting point and a lower solubility in a solvent, and is more excellent in stability than the conventionally known reduced coenzyme Q10 crystal.
Opening claim text (preview).
The invention claimed is: 1. A composition, comprising: a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles in 20±0.2° of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° in powder Cu—Kα X-ray diffraction, wherein the composition is in a solid form and the composition is at least one of food, nutritional functional food, specified health food, nutritious supplement, nutrient, animal drug, feed, cosmetic, medicament, treatment drug, prevention drug, and pet food. 2. The composition of claim 1 , further comprising: at least one of an excipient, a disintegrator, a lubricant, a binder, an antioxidant, a colorant, an anticoagulation agent, an absorption promoter, and an active ingredient which is not reduced coenzyme Q10. 3. The composition of claim 2 , wherein the active ingredient is at least one of amino acid, vitamin, mineral, polyphenol, organic acid, saccharide, peptide, and protein. 4. The composition of claim 1 , which is in a form of a hard capsule. 5. The composition of claim 2 , which is in a form of a hard capsule. 6. The composition of claim 3 , which is in a form of a hard capsule. 7. The composition of claim 1 , which is in a form of a tablet. 8. The composition of claim 2 , which is in a form of a tablet. 9. The composition of claim 3 , which is in a form of a tablet. 10. The composition of claim 1 , which is in a form of a coated tablet. 11. The composition of claim 2 , which is in a form of a coated tablet. 12. The composition of claim 3 , which is in a form of a coated tablet.
Nutrients, e.g. vitamins, minerals · CPC title
Aromatic compounds · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Separation; Purification; Stabilisation; Use of additives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.